Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas
- PMID: 12853836
- DOI: 10.1097/01.ju.0000074870.54671.98
Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas
Abstract
PURPOSE The von Hippel-Lindau (VHL) tumor suppressor gene is frequently inactivated in the common type of sporadic clear cell renal cell carcinoma (RCC) as well as RCCs associated with VHL disease. The VHL protein targets hypoxia-inducible factor-1 alpha (HIF-1 alpha), a transcription factor that can induce vascular endothelial growth factor (VEGF) expression, for ubiquitination and degradation. Accumulation of HIF-1 alpha caused by mutant VHL protein in tumor cells may result in VEGF over expression, which has been used to explain the increased vascularity of RCC. However, quantitative analyses of VEGF production and its correlation with VHL mutations and HIF-1 alpha expression in authentic tissues from patients with RCC are lacking.
Materials and methods: We analyzed VHL gene mutations by direct DNA sequencing and methylation specific polymerase chain reaction in 31 paired RCC tissue samples. HIF-1 alpha protein expression detected by immunoblotting and immunohistochemical staining, and VEGF protein measured by enzyme-linked immunosorbent assay and immunohistochemical staining were performed using tumor and corresponding normal tissues.
Results: VHL gene mutations were detected in 44% of clear cell RCCs but no differences in methylation patterns in the promoter or exon 1 were found. RCCs with VHL gene mutations or of advanced grade produced significantly higher concentrations of VEGF (p <0.0001). HIF-1 alpha protein expression was found in 40% of clear cell RCCs but 80% of them had VHL mutations (p <0.006). HIF-1 alpha expression correlated directly with higher levels of VEGF production (p <0.0001).
Conclusions: Our findings indicate that VHL gene alterations and HIF-1 alpha protein expression correlate with a significant increase in VEGF production by RCC. In turn it is associated with a more aggressive tumor phenotype.
Comment in
-
Molecular targeting of VHL gene pathway in clear cell kidney cancer.J Urol. 2003 Aug;170(2 Pt 1):593-4. doi: 10.1097/01.ju.0000077210.05543.ae. J Urol. 2003. PMID: 12853837 No abstract available.
Similar articles
-
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938. Oncogene. 2000. PMID: 11114720
-
Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas.Cancer Res. 2001 Jul 1;61(13):5215-22. Cancer Res. 2001. PMID: 11431362
-
Molecular targeting of VHL gene pathway in clear cell kidney cancer.J Urol. 2003 Aug;170(2 Pt 1):593-4. doi: 10.1097/01.ju.0000077210.05543.ae. J Urol. 2003. PMID: 12853837 No abstract available.
-
Von Hippel-Lindau disease.Microsc Res Tech. 2003 Feb 1;60(2):159-64. doi: 10.1002/jemt.10253. Microsc Res Tech. 2003. PMID: 12539169 Review.
-
The von Hippel-Lindau tumor suppressor gene and kidney cancer.Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6290S-5S. doi: 10.1158/1078-0432.CCR-sup-040025. Clin Cancer Res. 2004. PMID: 15448019 Review.
Cited by
-
The Efficacy and Safety of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor Combination Therapy for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Real-World Cohort Study.Cancers (Basel). 2023 Feb 2;15(3):947. doi: 10.3390/cancers15030947. Cancers (Basel). 2023. PMID: 36765903 Free PMC article.
-
Renal cell carcinoma and the use of sorafenib.Ther Clin Risk Manag. 2006 Mar;2(1):87-98. Ther Clin Risk Manag. 2006. PMID: 18360584 Free PMC article.
-
Retinal capillary hemangioma in a pthisical globe: Late sequelae in a case of Von Hippel-Lindau (VHL) disease presenting with endophthalmitis.Int J Surg Case Rep. 2025 Feb;127:110867. doi: 10.1016/j.ijscr.2025.110867. Epub 2025 Jan 12. Int J Surg Case Rep. 2025. PMID: 39809053 Free PMC article.
-
Ocular Manifestations of von Hippel-Lindau Disease.Cureus. 2019 Aug 4;11(8):e5319. doi: 10.7759/cureus.5319. Cureus. 2019. PMID: 31588386 Free PMC article. Review.
-
Molecular basis for the treatment of renal cell carcinoma.Clin Transl Oncol. 2010 Jan;12(1):15-21. doi: 10.1007/s12094-010-0461-4. Clin Transl Oncol. 2010. PMID: 20080466 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical